Doctors Note Logo

Published on: 7/2/2026

The Pre-GLP-1 Screening: What Your Doctor Should Test Before Injections

Before starting GLP-1 therapy, patients should complete several baseline evaluations to ensure safety and effectiveness. Key labs include fasting glucose, HbA1c, kidney and liver function tests, complete blood count, and a lipid panel. Specialized assessments—such as thyroid function, pancreatic enzymes (amylase and lipase), an ECG, and pregnancy testing when applicable—are also recommended. Equally important is a thorough review of your medical history, current medications, supplements, allergies, and lifestyle habits to identify potential risks and optimize dosing and tolerability.

Because GLP-1 readiness depends on how your symptoms and health history align with these factors, the smartest first step is to clarify what you're experiencing. Take a free, instant, online symptom check to better understand your symptoms and confidently navigate your next steps toward safe, effective treatment.

Reviewed for medical accuracy: 07/02/2026

answer background

Explanation

The Pre-GLP-1 Screening: What Your Doctor Should Test Before Injections

GLP-1 receptor agonists (often called "GLP-1s") have become a powerful tool in managing type 2 diabetes, obesity, and certain metabolic disorders. Before starting injections, a thorough, comprehensive health screening helps ensure safety, optimize dosing, and identify potential risks. Here's what you and your doctor should review and test before beginning GLP-1 therapy.

Why Comprehensive Health Screening Matters

GLP-1s work by mimicking the body's natural glucagon-like peptide-1 hormone, which regulates blood sugar, slows stomach emptying, and influences appetite. Because these medications affect multiple organ systems, pre-treatment tests can:

  • Reveal conditions that might require dose adjustments or alternative therapies
  • Identify existing issues (e.g., kidney or liver impairment) that could influence drug metabolism
  • Minimize risks of adverse reactions and maximize treatment benefits

A solid baseline also makes it easier to spot changes once you're on therapy, ensuring any side effects or complications are addressed promptly.

Core Laboratory Tests

Before starting GLP-1 injections, most clinicians will order the following basic panels:

  • Fasting Blood Glucose and HbA1c

    • Confirms current blood sugar control
    • Establishes a baseline to track improvements over time
  • Complete Metabolic Panel (CMP)

    • Kidney function: blood urea nitrogen (BUN), creatinine, estimated glomerular filtration rate (eGFR)
    • Liver function: alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase, bilirubin
    • Electrolytes and fluid balance: sodium, potassium, chloride, bicarbonate
  • Complete Blood Count (CBC)

    • Detects anemia, infection, or other blood disorders
    • Ensures overall blood health before therapy
  • Lipid Profile

    • Total cholesterol, LDL, HDL, triglycerides
    • Many GLP-1 patients have dyslipidemia; tracking lipids helps monitor heart disease risk

Specialized Assessments

Depending on your personal and family history, additional tests may be needed:

  • Thyroid Function Tests (TSH, free T4)

    • Some GLP-1s have been associated with rare cases of thyroid C-cell changes in animal studies (not confirmed in humans), so baseline thyroid status is prudent
  • Pancreatic Enzymes (Amylase, Lipase)

    • Though pancreatitis risk is low, it's wise to have baseline levels if you have a history of gallstones or unexplained abdominal pain
  • Electrocardiogram (ECG)

    • Recommended if you have known heart disease, irregular heartbeat, or other cardiac risk factors
  • Pregnancy Test

    • GLP-1s aren't approved for use during pregnancy; a negative test is necessary if pregnancy is possible
  • Vitamin B12 Level

    • Long-term use of some diabetes medications can affect B12 absorption; establish your baseline now

Reviewing Medical History and Physical Exam

Lab tests are only part of the picture. A thorough review of your health history and a focused physical exam will cover:

  • Medical Conditions

    • Pancreatitis or gallbladder disease
    • Kidney or liver disease
    • Heart disease or arrhythmias
    • Gastrointestinal disorders (e.g., gastroparesis)
  • Current Medications and Supplements

    • Some drugs may interact or increase risks (e.g., certain anti-inflammatories, antiplatelets)
    • Herbal remedies and over-the-counter supplements can impact blood sugar and GI function
  • Allergies and Past Reactions

    • Prior injection site reactions or sensitivities to excipients in injectable drugs
  • Lifestyle Factors

    • Diet, exercise habits, alcohol intake, smoking status
    • These will guide counseling on how GLP-1 therapy fits into your broader lifestyle plan
  • Family History

    • Thyroid disease, pancreatic disorders, heart disease, or early-onset diabetes

Patient Education and Expectations

Before initiating therapy, a candid discussion helps set expectations and reduce anxiety:

  • Possible digestive side effects (nausea, vomiting, diarrhea) and how to manage them
  • Importance of gradual dose titration to improve tolerability
  • Meal timing and portion adjustments
  • Monitoring blood sugar more closely during the first weeks

Encourage questions so you feel fully informed. If you have any new or unexplained symptoms—such as severe abdominal pain, persistent heartburn, or chest discomfort—it's important to seek medical advice right away.

Digital Tools for Early Symptom Assessment

If you're ever unsure about new or changing symptoms before or after starting GLP-1 therapy, try using a Medically approved LLM Symptom Checker Chat Bot to get personalized guidance and determine whether you should monitor at home or contact your healthcare provider right away.

When to Adjust or Delay Treatment

Certain findings on pre-treatment tests can prompt a delay or modification of your GLP-1 plan:

  • eGFR below recommended thresholds (varies by medication) may require dose adjustment or alternative therapy
  • Elevated liver enzymes indicating acute liver injury
  • Active gallstones or history of severe gallbladder disease waiting resolution
  • Uncontrolled thyroid disease until stabilized

Your doctor will weigh the benefits and risks and discuss whether GLP-1 therapy, dose changes, or even a different class of medication is best for you.

Ongoing Monitoring After Starting GLP-1

Once injections begin, a follow-up schedule helps ensure safety and effectiveness:

  • Every 3 months: HbA1c, kidney and liver function, electrolytes
  • Every 6–12 months: Lipid profile, thyroid tests, CBC
  • As needed: Amylase/lipase if you develop abdominal symptoms, ECG if new cardiac signs appear

Frequent check-ins allow for timely dose adjustments and early detection of side effects.

Balancing Benefits and Risks

GLP-1 receptor agonists offer significant advantages:

  • Better blood sugar control
  • Weight loss and reduced appetite
  • Potential cardiovascular benefits in certain patients

However, no therapy is risk-free. Up-front screening and ongoing monitoring help you reap the most benefit with the least risk.

Key Takeaways

  • Comprehensive health screening before GLP-1 injections protects your safety and optimizes therapy.
  • Core tests include glucose measures, metabolic panel, CBC, and lipid profile.
  • Specialized tests may cover thyroid, pancreatic enzymes, ECG, and pregnancy status.
  • A full medical history and physical exam are essential.
  • Digital symptom checkers can guide you on when to seek medical care.
  • Ongoing monitoring is crucial to track response and catch side effects early.

Always discuss your results and any concerns with your healthcare provider. If you experience serious or life-threatening symptoms, seek immediate medical attention. And remember to speak to a doctor before making any decisions about your health or treatment plan.

(References)

  • * American Diabetes Association. 10. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024. *Diabetes Care*, vol. 47, suppl. 1, 2024, pp. S158-S177. doi:10.2337/dc24-S010.

  • * Garber, A. J., et al. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary. *Endocrine Practice*, vol. 26, no. 1, 2020, pp. 107-133. doi:10.4158/CS-2019-0527.

  • * Nauck, M. M., & Meier, J. J. GLP-1 receptor agonists: mechanisms of action, clinical applications, and safety profile. *Nature Reviews Endocrinology*, vol. 17, no. 6, 2021, pp. 349-366. doi:10.1038/s41574-021-00481-2.

  • * Lingvay, I., et al. Initiating and optimizing GLP-1 receptor agonist therapy in type 2 diabetes: A practical guide for clinicians. *Diabetes, Obesity and Metabolism*, vol. 24, no. 1, 2022, pp. 1-13. doi:10.1111/dom.14555.

  • * Smits, M. M., & van Raalte, D. H. Safety of GLP-1 receptor agonists: focus on pancreatitis, gallbladder, and thyroid. *Current Opinion in Endocrinology, Diabetes and Obesity*, vol. 28, no. 1, 2021, pp. 21-27. doi:10.1097/MED.0000000000000623.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.